Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611 1654 1658
This examiner grants 44% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18030433 | CHIMERIC CONJUGATES FOR DEGRADATION OF VIRAL AND HOST PROTEINS AND METHODS OF USE | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18278508 | COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING DISEASE CAUSED BY PROTEIN NITRATION COMPRISING PEPTIDE WITH TERMINAL TYROSINE AS EFFECTIVE COMPONENT | Non-Final OA | INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY |
| 18249858 | FUSION PROTEIN TARGETING MITOCHONDRIA, METHOD OF MAKING AND USE THEREOF | Non-Final OA | UNIVERSITY OF ROCHESTER |
| 18338477 | Paclitaxel Prodrug, Preparation Method and Application Thereof | Final Rejection | WEST CHINA HOSPITAL, SICHUAN UNIVERSITY |
| 18024624 | PEPTIDES ENDOWED WITH ANGIOGENIC ACTIVITY | Non-Final OA | Dompe' Farmaceutici SPA |
| 18273868 | Treatment Of Integrin-Related Disorders With Stapled Peptides | Non-Final OA | Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center |
| 18359420 | DELTA T-CELL OR GAMMA RECEPTOR CHAINS OR PARTS THEREOF FOR TREATING OVARIAN CANCER | Non-Final OA | Gadeta B.V. |
| 18340863 | PEPTIDE HYDROGEL COMPRISING HYDROPHILIC AZIDE-CONTAINING AMINO ACID AND ITS USE | Non-Final OA | The United States of America, as represented by the Secretary, Department of Health and Human servi |
| 18139254 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES WITH a4B7 INTEGRIN ANTAGONISTS | Non-Final OA | Protagonist Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy